Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
OncoCyte Corp (GB:0KCC)
LSE:0KCC
OncoCyte (0KCC) Share Price & Analysis
0 Followers
0KCC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.32 - $5.60
Previous Close$2.49
Volume0.00
Average Volume (3M)1.32K
Market Cap
$20.31M
Enterprise Value$6.07M
Total Cash (Recent Filing)$14.24M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.1
Beta0.56
Next Earnings
May 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-23.74
Shares Outstanding8,273,073
10 Day Avg. Volume2
30 Day Avg. Volume1,318
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-1.07
Price to Sales (P/S)37.19
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-2.57
Enterprise Value/Gross Profit77.81
Enterprise Value/Ebitda6.98
Forecast
1Y Price Target
$4.25Price Target Upside70.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
OncoCyte News
PremiumCompany Announcements
OncoCyte Corp Announces Equity Placement and Fundraising Efforts
0KCC FAQ
What was OncoCyte Corp’s price range in the past 12 months?
OncoCyte Corp lowest share price was $2.31 and its highest was $5.60 in the past 12 months.
What is OncoCyte Corp’s market cap?
Currently, no data Available
When is OncoCyte Corp’s upcoming earnings report date?
OncoCyte Corp’s upcoming earnings report date is May 14, 2024 which is in 19 days.
How were OncoCyte Corp’s earnings last quarter?
OncoCyte Corp released its earnings results on Apr 12, 2024. The company reported -$2.27 earnings per share for the quarter, missing the consensus estimate of -$0.67 by -$1.6.
Is OncoCyte Corp overvalued?
According to Wall Street analysts OncoCyte Corp’s price is currently Undervalued.
Does OncoCyte Corp pay dividends?
OncoCyte Corp does not currently pay dividends.
What is OncoCyte Corp’s EPS estimate?
OncoCyte Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoCyte Corp have?
OncoCyte Corp has 8,273,073 shares outstanding.
What happened to OncoCyte Corp’s price movement after its last earnings report?
OncoCyte Corp reported an EPS of -$2.27 in its last earnings report, missing expectations of -$0.67. Following the earnings report the stock price went up 62.092%.
Which hedge fund is a major shareholder of OncoCyte Corp?
Among the largest hedge funds holding OncoCyte Corp’s share is Defender Capital, LLC.. It holds OncoCyte Corp’s shares valued at 179K.
---
OncoCyte Stock Smart Score
Company Description
OncoCyte Corp
OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.
---
0KCC Earnings Call
Q4 2024
0:00 / 0:00
---
0KCC Stock 12 Months Forecast
Average Price Target
$4.25
▲(70.68% Upside)
Technical Analysis
Best Analysts Covering 0KCC
1 Year
1 Year Success Rate
0/18 ratings generated profit
1 Year Average Return
-66.66%
reiterated a buy rating 2 days ago
Copying Michael Matson's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -66.66% per trade.
---